These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 27233264)

  • 1. Infectious Viral Quantification of Chikungunya Virus-Virus Plaque Assay.
    Kaur P; Lee RC; Chu JJ
    Methods Mol Biol; 2016; 1426():93-103. PubMed ID: 27233264
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neutralization Assay for Chikungunya Virus Infection: Plaque Reduction Neutralization Test.
    Azami NA; Moi ML; Takasaki T
    Methods Mol Biol; 2016; 1426():273-82. PubMed ID: 27233280
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chikungunya Virus Growth and Fluorescent Labeling: Detection of Chikungunya Virus by Immunofluorescence Assay.
    Moi ML; Takasaki T
    Methods Mol Biol; 2016; 1426():143-52. PubMed ID: 27233268
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A flow cytometric granularity assay for the quantification of infectious virus.
    Logan M; Manalil J; Notte C; Kearse C; George S; Zeiser A; Farrell P; Aucoin MG
    Vaccine; 2019 Nov; 37(47):7090-7099. PubMed ID: 31630940
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A direct plaque assay for Mount Elgon bat virus.
    Gomwalk NE
    J Virol Methods; 1980; 1(4):201-8. PubMed ID: 7276123
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A mutant of chikungunya virus isolated from a line of Singh's Aedes albopictus cells by plaque formation on virus-sensitive cloned cells obtained from another Singh's A. albopictus cell line.
    Igarashi A
    Virology; 1979 Oct; 98(2):385-92. PubMed ID: 506067
    [No Abstract]   [Full Text] [Related]  

  • 7. Titer distribution analysis of chikungunya virus in Aedes albopictus (Diptera: Culicidae).
    Konishi E; Yamanishi H
    J Med Entomol; 1986 Jan; 23(1):92-8. PubMed ID: 3950931
    [No Abstract]   [Full Text] [Related]  

  • 8. Mefenamic acid in combination with ribavirin shows significant effects in reducing chikungunya virus infection in vitro and in vivo.
    Rothan HA; Bahrani H; Abdulrahman AY; Mohamed Z; Teoh TC; Othman S; Rashid NN; Rahman NA; Yusof R
    Antiviral Res; 2016 Mar; 127():50-6. PubMed ID: 26794398
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Resolving the titer of murine cytomegalovirus by plaque assay using the M2-10B4 cell line and a low viscosity overlay.
    Zurbach KA; Moghbeli T; Snyder CM
    Virol J; 2014 Apr; 11():71. PubMed ID: 24742045
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Suramin Inhibits Chikungunya Virus Entry and Transmission.
    Ho YJ; Wang YM; Lu JW; Wu TY; Lin LI; Kuo SC; Lin CC
    PLoS One; 2015; 10(7):e0133511. PubMed ID: 26208101
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of cell-based and PCR-based assays as methods for measuring infectivity of Tulane virus.
    Shan L; Yang D; Wang D; Tian P
    J Virol Methods; 2016 May; 231():1-7. PubMed ID: 26875997
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic divergence of Chikungunya virus plaque variants from the Comoros Island (2005).
    Wasonga C; Inoue S; Rumberia C; Michuki G; Kimotho J; Ongus JR; Sang R; Musila L
    Virus Genes; 2015 Dec; 51(3):323-8. PubMed ID: 26347221
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plaque assay for murine norovirus.
    Gonzalez-Hernandez MB; Bragazzi Cunha J; Wobus CE
    J Vis Exp; 2012 Aug; (66):e4297. PubMed ID: 22951568
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro infectivity of oncolytic Newcastle Disease Virus: Correlation between plaque and fluorescent focus assays.
    Rush BS; Coughlin ML; Sanyal G
    J Virol Methods; 2018 Jan; 251():69-74. PubMed ID: 28982603
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunostained plaque assay for detection and titration of rabies virus infectivity.
    Park JS; Um J; Choi YK; Lee YS; Ju YR; Kim SY
    J Virol Methods; 2016 Feb; 228():21-5. PubMed ID: 26569350
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantification of RSV Infectious Particles by Plaque Assay and Immunostaining Assay.
    Jorquera PA; Tripp RA
    Methods Mol Biol; 2016; 1442():33-40. PubMed ID: 27464685
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of the plaque assay and 50% tissue culture infectious dose assay as methods for measuring filovirus infectivity.
    Smither SJ; Lear-Rooney C; Biggins J; Pettitt J; Lever MS; Olinger GG
    J Virol Methods; 2013 Nov; 193(2):565-71. PubMed ID: 23748121
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiviral activity of silymarin against chikungunya virus.
    Lani R; Hassandarvish P; Chiam CW; Moghaddam E; Chu JJ; Rausalu K; Merits A; Higgs S; Vanlandingham D; Abu Bakar S; Zandi K
    Sci Rep; 2015 Jun; 5():11421. PubMed ID: 26078201
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of a micro-neutralization test for chikungunya virus.
    Raharjo E; Tadano M; Okamoto Y; Okuno Y
    Biken J; 1986 Mar; 29(1):27-30. PubMed ID: 3022710
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Optimal conditions for titration of SV40 by the plaque assay method.
    Fendrick JL; Hallick LM
    J Virol Methods; 1983 Aug; 7(2):93-102. PubMed ID: 6195175
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.